Skip to main content

Table 1 RNA-seq and ATAC-seq patient profile

From: Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients

Patient profile Tissue ID Overall survival (days) Onset age Sex ATAC-seq RNA-seq
Short-survival (chemoresistant; CR)
(< 0.5 years)
Short-Survival-1 145 58 M v v
Short-Survival-2 147 72 F v v
Short-Survival-3 173 58 M - v
Short-Survival-4 183 68 F v v
Short-Survival-5 112 41 M v
Long-survival (chemosensitive; CS)
(> 2 years)
Long-survival-1 1500 58 M v v
Long-survival-2 2633 57 M - v
Long-survival-3 1037 61 M v v
Long-survival-4 1461 54 M v v
Long-survival-5 1597 54 F v
Normal Normal-1   63 F v v
Normal-2   54 M v v
Normal-3   53 M v
Normal-4   65 M v